Browse
Register
Log In
Variables
4291 variables.
Search variables
---------
Activity tracker (CHRIS follow-up) (md_x1_0139)
Administrative data (CHRIS baseline) (md_x0_0022)
Administrative data (CHRIS follow-up) (md_x1_0022)
Affinity-based plasma proteomics (CHRIS baseline) (md_x0_0103)
Affinity-based plasma proteomics (Upcoming, CHRIS baseline) (md_up_0011)
Alcohol (CHRIS baseline) (md_x0_0037)
Alcohol (CHRIS follow-up) (md_x1_0037)
Anthropometry (CHRIS baseline) (md_x0_0012)
Anthropometry (CHRIS follow-up) (md_x1_0012)
Anthropometry form (CHRIS follow-up) (md_x1_0135)
Anxiety (CHRIS baseline) (md_x0_0098)
Anxiety (CHRIS follow-up) (md_x1_0098)
Arthritis (CHRIS follow-up) (md_x1_0130)
Autonomic system (CHRIS baseline) (md_x0_0089)
Autonomic system (CHRIS follow-up) (md_x1_0089)
Baseline information (CHRIS COVID-19) (md_cc_0002)
Biochemical traits (CHRIS COVID-19) (md_cc_0003)
Biochemical traits (CHRIS baseline) (md_x0_0002)
Biochemical traits (CHRIS follow-up) (md_x1_0002)
Birth (CHRIS baseline) (md_x0_0038)
Blood (CHRIS COVID-19) (ms_cc_0002)
Blood (CHRIS NAFLD) (ms_na_0002)
Blood (CHRIS PAREGEN1) (ms_p1_0002)
Blood (CHRIS PAREGEN2) (ms_p2_0002)
Blood (CHRIS baseline) (ms_x0_0002)
Blood (CHRIS follow-up) (ms_x1_0002)
Blood collection form (CHRIS baseline) (md_x0_0007)
Blood collection form (CHRIS follow-up) (md_x1_0007)
Blood drawing pain rating (CHRIS follow-up) (md_x1_0134)
Blood measurements (CHRIS baseline) (md_x0_0009)
Blood measurements (CHRIS follow-up) (md_x1_0009)
Blood pressure (CHRIS baseline) (md_x0_0013)
Blood pressure (CHRIS follow-up) (md_x1_0013)
Blood values (CHRIS baseline) (md_x0_0039)
Blood values (CHRIS follow-up) (md_x1_0039)
CHRIS COVID-19 data (md_cc_0001)
CHRIS COVID-19 samples (ms_cc_0001)
CHRIS NAFLD data (md_na_0001)
CHRIS NAFLD samples (ms_na_0001)
CHRIS PAREGEN1 data (md_p1_0001)
CHRIS PAREGEN1 samples (ms_p1_0001)
CHRIS PAREGEN2 data (md_p2_0001)
CHRIS PAREGEN2 samples (ms_p2_0001)
CHRIS baseline data (md_x0_0001)
CHRIS baseline samples (ms_x0_0001)
CHRIS data (md_x_0001)
CHRIS follow-up data (md_x1_0001)
CHRIS follow-up data (Upcoming CHRIS follow-up) (md_up_0010)
CHRIS follow-up samples (ms_x1_0001)
CHRIS samples (ms_x_0001)
CHRIS sub-study data (md_xs_0001)
CHRIS sub-study samples (ms_xs_0001)
COVID-19 infection (CHRIS follow-up) (md_x1_0123)
COVID-19 vaccination (CHRIS follow-up) (md_x1_0117)
Cancer (CHRIS baseline) (md_x0_0040)
Cancer (CHRIS follow-up) (md_x1_0040)
Cardiac arrhythmias (CHRIS baseline) (md_x0_0041)
Cardiac arrhythmias (CHRIS follow-up) (md_x1_0041)
Cardiovascular diseases (CHRIS baseline) (md_x0_0042)
Cardiovascular diseases (CHRIS baseline) (md_x0_0107)
Cardiovascular traits (CHRIS baseline) (md_x0_0114)
Cardiovascular traits (CHRIS follow-up) (md_x1_0114)
Childhood trauma (CHRIS baseline) (md_x0_0081)
Chronic diseases (CHRIS baseline) (md_x0_0043)
Chronic diseases (CHRIS follow-up) (md_x1_0043)
Chronic pain (CHRIS baseline) (md_x0_0044)
Chronic pain (CHRIS follow-up) (md_x1_0124)
Chronotype (CHRIS baseline) (md_x0_0091)
Circulation (CHRIS baseline) (md_x0_0045)
Circulation (CHRIS follow-up) (md_x1_0045)
Clinical traits (CHRIS baseline) (md_x0_0011)
Clinical traits (CHRIS follow-up) (md_x1_0011)
Cognition (CHRIS baseline) (md_x0_0070)
Complement system (CHRIS baseline) (md_x0_0004)
Complement system, additional batch (Upcoming, CHRIS baseline) (md_up_0009)
Continuous blood pressure measurement (CHRIS baseline) (md_x0_0118)
Corticosteroids (Upcoming, CHRIS baseline) (md_up_0008)
Cumulative Illness Rating Scale (CHRIS baseline) (md_x0_0115)
Data-derived traits (CHRIS baseline) (md_x0_0106)
Data-derived traits (CHRIS follow-up) (md_x1_0106)
Day summary (md_x1_0140)
Demographic data (CHRIS baseline) (md_x0_0024)
Demographic data (CHRIS follow-up) (md_x1_0024)
Depression (CHRIS baseline) (md_x0_0090)
Depression (CHRIS follow-up) (md_x1_0090)
Depression and mania (CHRIS baseline) (md_x0_0085)
Derived traits (CHRIS baseline) (md_x0_0104)
Derived traits (CHRIS follow-up) (md_x1_0104)
Diabetes (CHRIS baseline) (md_x0_0046)
Diabetes (CHRIS follow-up) (md_x1_0046)
Drug intake (CHRIS baseline) (md_x0_0018)
Drug intake (CHRIS follow-up) (md_x1_0018)
Drugs complete dataset (CHRIS follow-up) (md_x1_0019)
Drugs summary (CHRIS baseline) (md_x0_0020)
Drugs summary (CHRIS follow-up) (md_x1_0020)
Dynamic consent survey (CHRIS baseline) (md_x0_0109)
ECG 10s (CHRIS baseline) (md_x0_0015)
ECG 10s (CHRIS follow-up) (md_x1_0015)
ECG 20m (CHRIS baseline) (md_x0_0016)
ECG representations based on 32 generative factors (Upcoming, CHRIS baseline) (md_up_0015)
Early repolarization pattern (CHRIS baseline) (md_x0_0116)
Exposure (CHRIS baseline) (md_x0_0047)
Feces (CHRIS NAFLD) (ms_na_0005)
Flavonoid intake (CHRIS baseline) (md_x0_0078)
Flavonoid intake (CHRIS follow-up) (md_x1_0078)
Food frequency questionnaire (CHRIS baseline) (md_x0_0077)
Food frequency questionnaire (CHRIS follow-up) (md_x1_0077)
General health (CHRIS follow-up) (md_x1_0128)
General information (CHRIS COVID-19) (md_cc_0004)
General information (CHRIS baseline) (md_x0_0021)
General information (CHRIS follow-up) (md_x1_0021)
Genomic variants (CHRIS baseline) (md_x0_0026)
Genomics (CHRIS baseline) (md_x0_0025)
Genotype array (CHRIS baseline) (md_x0_0028)
Gynecology (CHRIS baseline) (md_x0_0048)
Gynecology (CHRIS follow-up) (md_x1_0048)
Handedness (CHRIS follow-up) (md_x1_0136)
Heart failure (CHRIS baseline) (md_x0_0049)
Heart failure (CHRIS follow-up) (md_x1_0049)
Heart rate variability (CHRIS baseline) (md_x0_0113)
Heart rate variability, cardiologist curated (CHRIS baseline) (md_x0_0112)
Hypertension (CHRIS follow-up) (md_x1_0116)
Hypomania (CHRIS baseline) (md_x0_0082)
Illness rating (CHRIS follow-up) (md_x1_0129)
Infectious diseases (CHRIS follow-up) (md_x1_0122)
Informed consent (CHRIS follow-up) (md_x1_0110)
Informed consent (CHRIS baseline) (md_x0_0110)
Insomnia (CHRIS follow-up) (md_x1_0121)
Interpretation (CHRIS follow-up) (md_x1_0133)
Interview (CHRIS baseline) (md_x0_0036)
Interview (CHRIS follow-up) (md_x1_0036)
Iron metabolism (CHRIS baseline) (md_x0_0005)
Iron metabolism (Upcoming, CHRIS baseline) (md_up_0003)
Kidney diseases (CHRIS baseline) (md_x0_0050)
Kidney diseases (CHRIS follow-up) (md_x1_0050)
Lab routine measurements (CHRIS baseline) (md_x0_0008)
Lab routine measurements (CHRIS follow-up) (md_x1_0008)
Longitudinal information (CHRIS COVID-19) (md_cc_0005)
MICROS data (md_mi_0001)
MICROS samples (ms_mi_0001)
Major psychiatric diagnoses (CHRIS baseline) (md_x0_0084)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS COVID 19) (md_up_0014)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS baseline, CHRIS NAFLD) (md_up_0007)
Mass-spectrometry plasma proteomics: peptides (CHRIS NAFLD) (md_na_0101)
Mass-spectrometry plasma proteomics: peptides (CHRIS baseline) (md_x0_0101)
Mass-spectrometry plasma proteomics: proteins (CHRIS NAFLD) (md_na_0102)
Mass-spectrometry plasma proteomics: proteins (CHRIS baseline) (md_x0_0102)
Metabolomics (CHRIS NAFLD) (md_na_0063)
Metabolomics (CHRIS baseline) (md_x0_0063)
Metagenomes from saliva and feces (Upcoming, CHRIS NAFLD) (md_up_0016)
Migraine (CHRIS baseline) (md_x0_0051)
Mitochondrial DNA (Upcoming, CHRIS baseline) (md_up_0019)
Mitochondrial DNA copy number (CHRIS baseline) (md_x0_0006)
Movement disorder examination (CHRIS baseline) (md_x0_0111)
Myocardial infarction (CHRIS baseline) (md_x0_0052)
Myocardial infarction (CHRIS follow-up) (md_x1_0052)
NAFLD sub-study data (Upcoming CHRIS NAFLD) (md_up_0006)
NOT IN USE (md_x_0003)
NOT IN USE md_x0_0033 (md_x0_0033)
NOT IN USE md_x0_0034 (md_x0_0034)
NOT IN USE md_x0_0122 (md_x0_0122)
NOT IN USE md_x0_0123 (md_x0_0123)
NOT IN USE md_x0_0124 (md_x0_0124)
NOT IN USE md_x0_0125 (md_x0_0125)
NOT IN USE ms_x0_0005 (ms_x0_0005)
NOT IN USE ms_x0_0006 (ms_x0_0006)
NOT IN USE ms_x0_0007 (ms_x0_0007)
NOT IN USE ms_x0_0008 (ms_x0_0008)
NOT IN USE ms_x0_0009 (ms_x0_0009)
NOT IN USE ms_x0_0010 (ms_x0_0010)
NOT IN USE ms_x0_0011 (ms_x0_0011)
NOT IN USE test (test)
NOT IN USE upcoming_0001 (upcoming_0001)
NOT IN USE upcoming_0002 (upcoming_0002)
NOT IN USE upcoming_0003 (upcoming_0003)
NOT IN USE upcoming_0004 (upcoming_0004)
Neurological phenotypes (CHRIS baseline) (md_x0_0108)
Neurological phenotypes (CHRIS follow-up) (md_x1_0108)
Neurological tests (CHRIS baseline) (md_x0_0068)
Neurological tests (CHRIS follow-up) (md_x1_0068)
Neurology (CHRIS baseline) (md_x0_0053)
Neurology (CHRIS follow-up) (md_x1_0053)
Neuropsychiatry questionnaire (CHRIS baseline) (md_x0_0080)
Neutralizing Antibody (CHRIS COVID-19) (md_cc_0006)
Notes (CHRIS follow-up) (md_x1_0138)
Nutrient intake (CHRIS baseline) (md_x0_0079)
Nutrient intake (CHRIS follow-up) (md_x1_0079)
Nutrition (CHRIS baseline) (md_x0_0054)
Occupation (CHRIS baseline) (md_x0_0055)
Occupation (CHRIS follow-up) (md_x1_0055)
Olfaction (CHRIS follow-up) (md_x1_0118)
Olfactory test (CHRIS baseline) (md_x0_0071)
Olfactory test (CHRIS follow-up) (md_x1_0071)
Optimism and pessimism (CHRIS baseline) (md_x0_0083)
Oral health (CHRIS baseline) (md_x0_0099)
Other diseases (CHRIS baseline) (md_x0_0056)
PAREGEN sub-study data (Upcoming, CHRIS PAREGEN) (md_up_0017)
PAREGEN2 sub-study data (Upcoming, CHRIS PAREGEN2) (md_up_0018)
Pain Sensitivity (CHRIS follow-up) (md_x1_0092)
Pain pressure threshold (CHRIS baseline) (md_x0_0069)
Pain sensitivity (CHRIS baseline) (md_x0_0092)
Pain sensitivity assessement (CHRIS follow-up) (md_x1_0119)
Pain staging (CHRIS follow-up) (md_x1_0125)
Parkinson screening (CHRIS baseline) (md_x0_0057)
Participant satisfaction survey (CHRIS follow-up) (md_x1_0132)
Participation information (CHRIS baseline) (md_x0_0023)
Participation information (CHRIS follow-up) (md_x1_0023)
Pedigree (CHRIS baseline) (md_x0_0074)
Person (CHRIS baseline) (md_x0_0058)
Person (CHRIS follow-up) (md_x1_0058)
Physical activity (CHRIS baseline) (md_x0_0093)
Physical activity (CHRIS follow-up) (md_x1_0093)
Proteomics (CHRIS NAFLD) (md_na_0100)
Proteomics (CHRIS baseline) (md_x0_0100)
Public imputation panels (CHRIS baseline) (md_x0_0027)
REM sleep (CHRIS baseline) (md_x0_0095)
REM sleep (CHRIS follow-up) (md_x1_0095)
Raw recordings ECG 10s (CHRIS baseline) (md_x0_0119)
Raw recordings ECG 20m (CHRIS baseline) (md_x0_0120)
Raw recordings spiralography (CHRIS baseline) (md_x0_0121)
Renin-angiotensin-aldosteron system (Upcoming, CHRIS baseline) (md_up_0005)
Resting ECG (CHRIS baseline) (md_x0_0014)
Resting ECG (CHRIS follow-up) (md_x1_0014)
Restless Legs Syndrome (CHRIS baseline) (md_x0_0096)
SARS-CoV-2 antibody (CHRIS follow-up) (md_x1_0115)
Saliva (CHRIS NAFLD) (ms_na_0004)
Saliva (CHRIS baseline) (ms_x0_0004)
Saliva microbiome (Upcoming, CHRIS baseline) (md_up_0013)
Sample-derived traits (CHRIS baseline) (md_x0_0105)
Sample-derived traits (CHRIS follow-up) (md_x1_0105)
Self-Assessement (CHRIS baseline) (md_x0_0076)
Self-Assessement (CHRIS follow-up) (md_x1_0076)
Self-Assessement at home (CHRIS follow-up) (md_x1_0127)
Self-reported ancestry (CHRIS baseline) (md_x0_0075)
Sleep behavior (CHRIS follow-up) (md_x1_0120)
Sleep quality (CHRIS baseline) (md_x0_0094)
Smoking (CHRIS baseline) (md_x0_0059)
Smoking (CHRIS follow-up) (md_x1_0059)
Socio-economic panel (CHRIS follow-up) (md_x1_0126)
Socio-economic panel, at home (CHRIS follow-up) (md_x1_0131)
Spiralography (CHRIS baseline) (md_x0_0072)
Stress perception (CHRIS baseline) (md_x0_0086)
Stroke (CHRIS baseline) (md_x0_0060)
Stroke (CHRIS follow-up) (md_x1_0060)
Summary (md_x1_0141)
Surgeries (CHRIS follow-up) (md_x1_0137)
TOPMed-imputed genotypes (CHRIS baseline) - NOT IN USE (md_x0_0030)
Targeted serum metabolomics (CHRIS NAFLD) (md_na_0065)
Targeted serum metabolomics (CHRIS baseline) (md_x0_0065)
Targeted serum metabolomics, expanded set (CHRIS baseline) (md_x0_0064)
Targeted serum metabolomics, expanded set (Upcoming, CHRIS baseline) (md_up_0004)
Temperament (CHRIS baseline) (md_x0_0087)
Thyroid diseases (CHRIS baseline) (md_x0_0061)
Thyroid diseases (CHRIS follow-up) (md_x1_0061)
Touchscreen (CHRIS baseline) (md_x0_0088)
Touchscreen (CHRIS follow-up) (md_x1_0088)
Untargeted serum metabolomics (Upcoming, CHRIS baseline) (md_up_0012)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS NAFLD) (md_na_0066)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS baseline) (md_x0_0066)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS NAFLD) (md_na_0067)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS baseline) (md_x0_0067)
Upcoming datasets (md_up_0001)
Urine (CHRIS NAFLD) (ms_na_0003)
Urine (CHRIS baseline) (ms_x0_0003)
Urine (CHRIS follow-up) (ms_x1_0003)
Urine measurements (CHRIS baseline) (md_x0_0010)
Urine measurements (CHRIS follow-up) (md_x1_0010)
Vaccination (CHRIS baseline) (md_x0_0062)
Vaccination status (CHRIS COVID-19) (md_cc_0007)
Whole-exome sequencing (CHRIS baseline) (md_x0_0029)
Whole-exome sequencing imputation (CHRIS baseline) (md_x0_0031)
Whole-exome sequencing raw data (CHRIS baseline) (md_x0_0032)
Without expected release date (md_up_0002)
Module
---------
Label
Character
Integer
Categorical
Float
Date
Time
Datetime
Boolean
Type
Search
Clear
Module
Label
Name
Description
Type
ECG 10s (CHRIS baseline)
x0ec123l
R'-Amplitude, V6
Voltage amplitude of the peak of R wave in the first derivative of ECG, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec123f
R'-Amplitude, aVF
Voltage amplitude of the peak of R wave in the first derivative of ECG, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec123e
R'-Amplitude, aVL
Voltage amplitude of the peak of R wave in the first derivative of ECG, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec123d
R'-Amplitude, aVR
Voltage amplitude of the peak of R wave in the first derivative of ECG, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec121a
R-Amplitude, I
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec121b
R-Amplitude, II
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec121c
R-Amplitude, III
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec121g
R-Amplitude, V1
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec121h
R-Amplitude, V2
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec121i
R-Amplitude, V3
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec121j
R-Amplitude, V4
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec121k
R-Amplitude, V5
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec121l
R-Amplitude, V6
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec121f
R-Amplitude, aVF
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec121e
R-Amplitude, aVL
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec121d
R-Amplitude, aVR
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead aVR
Float
Restless Legs Syndrome (CHRIS baseline)
x0rd08
RLS duration (years)
RLS-D duration
Float
Heart rate variability (CHRIS baseline)
x0ec217
RMSSD
RMSSD: Square root of the mean squared differences between successive RR intervals, expressed in milliseconds
Float
Heart rate variability (CHRIS baseline)
x0ec281
RPA Lmean
RPA Lmean: Recurrence Plot Analysis is another approach for analyzing the complexity of the RR series, which consists in creating a symmetrical matrix of zeros and ones. Lmean is the average diagonal line length
Float
Heart rate variability (CHRIS baseline)
x0ec282
RPA Shannon Entropy
RPA Shannon Entropy: it is the entropy of the probability distribution of the diagonal line lengths
Float
Heart rate variability (CHRIS baseline)
x0ec278
RPA determinism
RPA determinism: Recurrence Plot Analysis is another approach for analyzing the complexity of the RR series, which consists in creating a symmetrical matrix of zeros and ones. The determinism (DET) is defined as the percentage of recurrence points which form diagonal lines
Float
Heart rate variability (CHRIS baseline)
x0ec279
RPA divergence
RPA divergence: Recurrence Plot Analysis is another approach for analyzing the complexity of the RR series, which consists in creating a symmetrical matrix of zeros and ones. The divergence (DIV) is defined as the inverse of Lmax
Float
Heart rate variability (CHRIS baseline)
x0ec277
RPA recurrence rate
RPA recurrence rate: Recurrence Plot Analysis is another approach for analyzing the complexity of the RR series, which consists in creating a symmetrical matrix of zeros and ones. The recurrence rate (REC) is defined as the ratio of ones and zeros in this RP matrix
Float
Blood measurements (CHRIS baseline)
x0lp40
Red Blood Cell Count (RBC)
Red Blood Cell Count (RBC)
Float
Blood measurements (CHRIS baseline)
x0lp46
Red Blood Cell Distribution Width (RDW)
Red Blood Cell Distribution Width (RDW)
Float
General information (CHRIS COVID-19)
cc_rsw
Relative sampling weight
Expansion sampling weight
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0re01
Respiratory Sinus Arrhythmia (RSA) (filtered)
Respiratory Sinus Arrhythmia (RSA) (filtered)
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0re02
Respiratory Sinus Arrhythmia (RSA) (open)
Respiratory Sinus Arrhythmia (RSA) (open)
Float
ECG 10s (CHRIS baseline)
x0ec128a
S'-Amplitude, I
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec128b
S'-Amplitude, II
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec128c
S'-Amplitude, III
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec128g
S'-Amplitude, V1
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec128h
S'-Amplitude, V2
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec128i
S'-Amplitude, V3
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec128j
S'-Amplitude, V4
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec128k
S'-Amplitude, V5
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec128l
S'-Amplitude, V6
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec128f
S'-Amplitude, aVF
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec128e
S'-Amplitude, aVL
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec128d
S'-Amplitude, aVR
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec126a
S-Amplitude, I
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec126b
S-Amplitude, II
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec126c
S-Amplitude, III
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec126g
S-Amplitude, V1
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec126h
S-Amplitude, V2
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec126i
S-Amplitude, V3
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec126j
S-Amplitude, V4
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec126k
S-Amplitude, V5
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec126l
S-Amplitude, V6
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec126f
S-Amplitude, aVF
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec126e
S-Amplitude, aVL
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec126d
S-Amplitude, aVR
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead aVR
Float
Heart rate variability (CHRIS baseline)
x0ec220
SDANN
SDANN: Standard deviation of the averages of RR intervals in 5-min segments, expressed in milliseconds
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt026
SDMA
Symmetric dimethylarginine
Float
Heart rate variability (CHRIS baseline)
x0ec216
SDNN
SDNN: Standard deviation of RR intervals, expressed in milliseconds
Float
Heart rate variability (CHRIS baseline)
x0ec221
SDNNI
SDNNI: Mean of the standard deviations of RR intervals in 5-min segments, expressed in milliseconds
Float
Heart rate variability (CHRIS baseline)
x0ec226
SI (Stress Index)
SI: Baevsky stress index, computed according to the formula given in Baevsky 2009, is a geometric measure of HRV reflecting cardiovascular system stress
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt162
SM (OH) C14:1
Hydroxysphingomyeline C14:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt163
SM (OH) C16:1
Hydroxysphingomyeline C16:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt164
SM (OH) C22:1
Hydroxysphingomyeline C22:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt165
SM (OH) C22:2
Hydroxysphingomyeline C22:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt166
SM (OH) C24:1
Hydroxysphingomyeline C24:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt167
SM C16:0
Sphingomyeline C16:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt168
SM C16:1
Sphingomyeline C16:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt169
SM C18:0
Sphingomyeline C18:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt170
SM C18:1
Sphingomyeline C18:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt171
SM C20:2
Sphingomyeline C20:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt172
SM C24:0
Sphingomyeline C24:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt173
SM C24:1
Sphingomyeline C24:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt174
SM C26:0
Sphingomyeline C26:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt175
SM C26:1
Sphingomyeline C26:1
Float
Heart rate variability (CHRIS baseline)
x0ec214
SNS index
SNS index
Float
Heart rate variability (CHRIS baseline)
x0ec214a
SNS param: nMeanHR
First parameter used for SNS index calculation: MeanHR normalized by scaling with the standard deviations of normal population
Float
Heart rate variability (CHRIS baseline)
x0ec214c
SNS param: nSD2
Third parameter used for SNS index calculation: SD2 normalized by scaling with the standard deviations of normal population
Float
Heart rate variability (CHRIS baseline)
x0ec214b
SNS param: nSI
Second parameter used for SNS index calculation: SI normalized by scaling with the standard deviations of normal population
Float
ECG 10s (CHRIS baseline)
x0ec129a
ST Value, I
ST segment deviation from the isoelectric line, defined as the difference between the voltage value at the beginning of T wave and the end of S wave (J point) expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec129b
ST Value, II
ST segment deviation from the isoelectric line, defined as the difference between the voltage value at the beginning of T wave and the end of S wave (J point) expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec129c
ST Value, III
ST segment deviation from the isoelectric line, defined as the difference between the voltage value at the beginning of T wave and the end of S wave (J point) expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec129g
ST Value, V1
ST segment deviation from the isoelectric line, defined as the difference between the voltage value at the beginning of T wave and the end of S wave (J point) expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec129h
ST Value, V2
ST segment deviation from the isoelectric line, defined as the difference between the voltage value at the beginning of T wave and the end of S wave (J point) expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec129i
ST Value, V3
ST segment deviation from the isoelectric line, defined as the difference between the voltage value at the beginning of T wave and the end of S wave (J point) expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec129j
ST Value, V4
ST segment deviation from the isoelectric line, defined as the difference between the voltage value at the beginning of T wave and the end of S wave (J point) expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec129k
ST Value, V5
ST segment deviation from the isoelectric line, defined as the difference between the voltage value at the beginning of T wave and the end of S wave (J point) expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec129l
ST Value, V6
ST segment deviation from the isoelectric line, defined as the difference between the voltage value at the beginning of T wave and the end of S wave (J point) expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec129f
ST Value, aVF
ST segment deviation from the isoelectric line, defined as the difference between the voltage value at the beginning of T wave and the end of S wave (J point) expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec129e
ST Value, aVL
ST segment deviation from the isoelectric line, defined as the difference between the voltage value at the beginning of T wave and the end of S wave (J point) expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec129d
ST Value, aVR
ST segment deviation from the isoelectric line, defined as the difference between the voltage value at the beginning of T wave and the end of S wave (J point) expressed in milliVolts, measured in lead aVR
Float
Heart rate variability (CHRIS baseline)
x0ec273
Sample Entropy
Sample Entropy: similar to ApEn, but it presents some differences in the calculation
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt025
Sarcosine
Sarcosine
Float
Baseline information (CHRIS COVID-19)
ccbq25
Self-reported weight
What is your weight?
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt027
Ser
Serine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt028
Serotonin
Serotonin
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec19
Short term scaling exponent of detrended fluctuation analysis (DFA alpha1)
Short term scaling exponent of detrended fluctuation analysis (DFA alpha1)
Float
Smoking (CHRIS baseline)
x0sm35
Smoking: Cigarettes (current)
How much do you now smoke on average? No. of Cigarettes/day (current)
Float
Smoking (CHRIS baseline)
x0sm44
Smoking: Pipe tobacco (past)
On average of the entire time you smoked, before you stopped or cut down, how much did you smoke? Pipe tobacco in grams/week (in the past)
Float
ECG 10s (CHRIS baseline)
x0ec142
Sokolow-Index
Sokolow-Index index for left ventricular hypertrophy, calculated as the sum of the amplitudes of the S wave in V1 and the R wave in V5 or V6 (whichever is larger), expressed in milliVolts [https://doi.org/10.1016/0002-8703(49)90562-1]
Float
Iron metabolism (CHRIS baseline)
x0he08a
Soluble transferrin receptor concentration, high stringency filter
Soluble transferrin receptor concentration with application of a high stringency filter
Float
Iron metabolism (CHRIS baseline)
x0he08b
Soluble transferrin receptor concentration, low stringency filter
Soluble transferrin receptor concentration with application of a low stringency filter
Float
Urine measurements (CHRIS baseline)
x0lp61a
Specific weight, urine
Specific weight, urine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt029
Spermidine
Spermidine
Float
Previous
1
31
32
33
34
35
43
Next